6-45422996-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001024630.4(RUNX2):c.423+39G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000565 in 1,591,938 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000049 ( 0 hom. )
Consequence
RUNX2
NM_001024630.4 intron
NM_001024630.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.45
Publications
1 publications found
Genes affected
RUNX2 (HGNC:10472): (RUNX family transcription factor 2) This gene is a member of the RUNX family of transcription factors and encodes a nuclear protein with an Runt DNA-binding domain. This protein is essential for osteoblastic differentiation and skeletal morphogenesis and acts as a scaffold for nucleic acids and regulatory factors involved in skeletal gene expression. The protein can bind DNA both as a monomer or, with more affinity, as a subunit of a heterodimeric complex. Two regions of potential trinucleotide repeat expansions are present in the N-terminal region of the encoded protein, and these and other mutations in this gene have been associated with the bone development disorder cleidocranial dysplasia (CCD). Transcript variants that encode different protein isoforms result from the use of alternate promoters as well as alternate splicing. [provided by RefSeq, Jul 2016]
RUNX2 Gene-Disease associations (from GenCC):
- cleidocranial dysplasia 1Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BS2
High AC in GnomAdExome4 at 7 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RUNX2 | NM_001024630.4 | c.423+39G>T | intron_variant | Intron 3 of 8 | ENST00000647337.2 | NP_001019801.3 | ||
| RUNX2 | NM_001369405.1 | c.381+39G>T | intron_variant | Intron 1 of 6 | NP_001356334.1 | |||
| RUNX2 | NM_001015051.4 | c.423+39G>T | intron_variant | Intron 3 of 7 | NP_001015051.3 | |||
| RUNX2 | NM_001278478.2 | c.381+39G>T | intron_variant | Intron 1 of 5 | NP_001265407.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151822Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
2
AN:
151822
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00 AC: 0AN: 210156 AF XY: 0.00
GnomAD2 exomes
AF:
AC:
0
AN:
210156
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000486 AC: 7AN: 1440116Hom.: 0 Cov.: 35 AF XY: 0.00000140 AC XY: 1AN XY: 716122 show subpopulations
GnomAD4 exome
AF:
AC:
7
AN:
1440116
Hom.:
Cov.:
35
AF XY:
AC XY:
1
AN XY:
716122
show subpopulations
African (AFR)
AF:
AC:
0
AN:
32986
American (AMR)
AF:
AC:
0
AN:
43532
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25706
East Asian (EAS)
AF:
AC:
0
AN:
38808
South Asian (SAS)
AF:
AC:
0
AN:
84992
European-Finnish (FIN)
AF:
AC:
0
AN:
45962
Middle Eastern (MID)
AF:
AC:
0
AN:
4158
European-Non Finnish (NFE)
AF:
AC:
7
AN:
1104532
Other (OTH)
AF:
AC:
0
AN:
59440
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151822Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74102 show subpopulations
GnomAD4 genome
AF:
AC:
2
AN:
151822
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
74102
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41362
American (AMR)
AF:
AC:
0
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5102
South Asian (SAS)
AF:
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
AC:
0
AN:
10580
Middle Eastern (MID)
AF:
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
AC:
2
AN:
67904
Other (OTH)
AF:
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.